Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE7.0300
- TODAY'S CHANGE (%)0.0900 (1.2968%)
- Bid / Lots6.9500/ 1
- Ask / Lots7.4100/ 1
- Open / Previous Close6.9800 / 6.9400
- Day Range
- 52 Week Range
- Volume132,162
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 1857 | 6.94 |
| 09:34 ET | 345 | 7.0092 |
| 09:36 ET | 8675 | 7.03 |
| 09:45 ET | 710 | 6.975 |
| 09:48 ET | 120 | 6.93 |
| 09:50 ET | 3161 | 6.81 |
| 09:52 ET | 2826 | 6.87 |
| 09:56 ET | 853 | 6.8501 |
| 10:01 ET | 342 | 6.89 |
| 10:03 ET | 579 | 6.89 |
| 10:06 ET | 200 | 6.85 |
| 10:10 ET | 962 | 6.855 |
| 10:12 ET | 100 | 6.85 |
| 10:14 ET | 202 | 6.855 |
| 10:15 ET | 100 | 6.89 |
| 10:21 ET | 100 | 6.91 |
| 10:24 ET | 107 | 6.91 |
| 10:26 ET | 1563 | 6.86 |
| 10:28 ET | 100 | 6.89 |
| 10:33 ET | 539 | 6.889 |
| 10:42 ET | 5000 | 6.87 |
| 10:46 ET | 369 | 6.88 |
| 10:53 ET | 1968 | 6.92 |
| 11:00 ET | 200 | 6.9638 |
| 11:04 ET | 700 | 6.98 |
| 11:06 ET | 300 | 7 |
| 11:08 ET | 100 | 7 |
| 11:09 ET | 197 | 6.98 |
| 11:18 ET | 538 | 7.03 |
| 11:20 ET | 100 | 7.0761 |
| 11:22 ET | 100 | 7.105 |
| 11:24 ET | 567 | 7.07 |
| 11:26 ET | 2281 | 7.05 |
| 11:27 ET | 829 | 7.05 |
| 11:29 ET | 120 | 7.02 |
| 11:31 ET | 100 | 7 |
| 11:33 ET | 220 | 7.02 |
| 11:36 ET | 1240 | 7.0221 |
| 11:40 ET | 240 | 6.98 |
| 11:44 ET | 100 | 7.02 |
| 11:45 ET | 360 | 6.99 |
| 11:49 ET | 100 | 6.98 |
| 11:54 ET | 1783 | 7.015 |
| 12:00 ET | 420 | 7.02 |
| 12:05 ET | 1204 | 7.04 |
| 12:07 ET | 100 | 7.035 |
| 12:12 ET | 690 | 7.03 |
| 12:14 ET | 120 | 7.03 |
| 12:21 ET | 1100 | 7.03 |
| 12:23 ET | 200 | 7.025 |
| 12:32 ET | 100 | 7.035 |
| 12:36 ET | 1880 | 7.01 |
| 12:43 ET | 200 | 6.99 |
| 12:45 ET | 153 | 6.98 |
| 12:54 ET | 490 | 6.93 |
| 12:56 ET | 350 | 6.975 |
| 12:57 ET | 100 | 6.95 |
| 01:01 ET | 590 | 6.95 |
| 01:08 ET | 700 | 6.955 |
| 01:10 ET | 1295 | 6.95 |
| 01:14 ET | 480 | 6.93 |
| 01:21 ET | 2548 | 6.94 |
| 01:24 ET | 450 | 6.92 |
| 01:26 ET | 4499 | 6.96 |
| 01:28 ET | 210 | 6.98 |
| 01:30 ET | 626 | 6.99 |
| 01:35 ET | 2010 | 7.01 |
| 01:37 ET | 980 | 6.97 |
| 01:42 ET | 340 | 7.005 |
| 01:46 ET | 737 | 7 |
| 01:50 ET | 1400 | 7.04 |
| 01:57 ET | 200 | 7.075 |
| 02:00 ET | 124 | 7.04 |
| 02:02 ET | 490 | 7.04 |
| 02:09 ET | 480 | 7.04 |
| 02:15 ET | 1000 | 7.065 |
| 02:20 ET | 100 | 7.04 |
| 02:22 ET | 581 | 7 |
| 02:29 ET | 480 | 7 |
| 02:31 ET | 934 | 7 |
| 02:33 ET | 1400 | 7.02 |
| 02:40 ET | 225 | 7.039 |
| 02:44 ET | 480 | 7.01 |
| 02:49 ET | 590 | 6.98 |
| 02:54 ET | 680 | 6.985 |
| 03:00 ET | 300 | 6.97 |
| 03:02 ET | 745 | 6.98 |
| 03:03 ET | 546 | 7.02 |
| 03:12 ET | 1724 | 6.99 |
| 03:14 ET | 100 | 6.99 |
| 03:16 ET | 200 | 6.99 |
| 03:18 ET | 890 | 6.995 |
| 03:23 ET | 767 | 7.002 |
| 03:30 ET | 500 | 6.96 |
| 03:32 ET | 200 | 6.976 |
| 03:34 ET | 167 | 6.98 |
| 03:36 ET | 490 | 6.96 |
| 03:38 ET | 1000 | 6.97 |
| 03:39 ET | 990 | 6.965 |
| 03:41 ET | 800 | 6.97 |
| 03:43 ET | 200 | 6.97 |
| 03:45 ET | 1743 | 6.99 |
| 03:52 ET | 1020 | 7.03 |
| 03:54 ET | 300 | 7.0201 |
| 03:56 ET | 700 | 7.0201 |
| 03:57 ET | 1928 | 7.03 |
| 03:59 ET | 20392 | 7.03 |
Sep 4, 2024
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors, from 8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference, from 8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 222.7M | -4.1x | --- |
Acrivon Therapeutics Inc | 223.9M | -2.6x | --- |
Gossamer Bio Inc | 226.2M | -2.5x | --- |
Compass Therapeutics Inc. | 218.8M | -4.8x | --- |
Omeros Corp | 218.5M | -1.2x | --- |
Corbus Pharmaceuticals Holdings Inc | 228.7M | -3.2x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Vice President - Development Leader
- Christopher Matheny
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $222.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.70 |
Book Value | $0.44 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
